Munich, Germany

Barbara Kreutzkamp

This inventor holds 2 USPTO granted patents. Top assignees: Klaus Keplinger, Other. Active years: 1989-1990.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 1989-1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Barbara Kreutzkamp: Innovator in Immunologic System Stimulation

Introduction

Barbara Kreutzkamp is a notable inventor based in Munich, Germany. She has made significant contributions to the field of immunology through her innovative research and patents. With a total of 2 patents, her work focuses on the development of oxindole alkaloids that stimulate the immunologic system.

Latest Patents

Kreutzkamp's latest patents include oxindole alkaloids that have properties stimulating the immunologic system. Specifically, her work on tetra- and pentacyclic oxindole alkaloids, particularly the alloisopteropodine, isomer A, demonstrates their suitability for unspecific stimulation of the immunologic system. This has been validated by substantial increases in phagocytosis in granulocytic tests and significant enhancements in the chemiluminescence response. Additionally, her research shows a marked increase in the phagocytosis activity of tissue macrophages in the reticuloendothelial system, as evidenced by the carbon-clearance test.

Career Highlights

Throughout her career, Kreutzkamp has worked with various companies, including Klaus Keplinger. Her innovative approach and dedication to research have positioned her as a key figure in her field.

Collaborations

Kreutzkamp has collaborated with notable individuals such as Klaus Keplinger and Hildebert Wagner. These partnerships have further enriched her research and contributions to immunology.

Conclusion

Barbara Kreutzkamp's work in developing oxindole alkaloids for immunologic stimulation showcases her innovative spirit and dedication to advancing medical science. Her contributions are significant in the ongoing quest to enhance immune system responses.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…